Skip to main content

Table 1 Sample information

From: Systematic analysis of gene expression in human brains before and after death

Sample* Age (years) Sex 28S/18S ratio GAPDH 5'/3' ratio Expressed probe sets (%)§ Diagnosis Epilepsy Types of seizures
HA1 70 M 1.2 0.445 50.6 - - -
HA3 45 M 1.6 0.637 49.7 - - -
HA4 45 M 1.2 0.507 49.4 - - -
HA5 54 F 1.6 0.712 51.7 - - -
HR1 45 M 1.1 0.520 50.5 Anaplastisches Oligo WHO III Yes Simple partial
HR2 39 F 1.3 0.700 50.2 Glioblastoma Yes Simple and complex partial, GM
HR3 61 M 1.6 0.774 53.8 Glioblastoma Yes Simple and complex partial
HR4 51 F 1.6 0.697 49.5 Ammon's horn sclerosis Yes Simple and complex partial, GM
HR5 13 M 1.4 0.778 47.1 Ganglioglioma Yes Complex partial
HR6 83 F 1.3 0.817 50.0 Atpisches Meningeom Grad II No -
CA1 45 M 1.4 0.870 51.0 - - -
CA2 45 M 1.4 0.841 51.4 - - -
CA3 48 M 1.5 0.865 53.2 - - -
CA5 70 M 1.4 0.669 47.2 - - -
CA6 82 F 1.7 0.690 47.7 - - -
CA7 67 M NA 0.810 49.5 - - -
CR1 35 F 1.2 0.741 45.9 Focal cortical dysplasia Yes Complex partial, GM
CR2 31 F 1.3 0.741 39.5 Focal cortical dysplasia Yes Simple partial
CR3 9 F NA 0.607 45.6 Focal cortical dysplasia Yes Complex partial
CR4 37 M NA 0.674 43.7 Focal cortical dysplasia Yes Complex partial
CR5 35 F NA 0.737 48.8 Focal cortical dysplasia Yes Complex partial, GM
CR6 31 F NA 0.674 43.1 Focal cortical dysplasia Yes Simple partial
  1. *Sample names: position one = brain region (H, hippocampus; C, cortex); position two = sample source (A, autopsy; R, resection); position three = individual. Ribosomal RNA bands ratio was measured using Agilent 2100 Bionalyzer system. GAPDH ratio was measured using probes to 5' and 3' of the transcript on Affymetrix® array. §Expressed probesets were defined based on detection p < 0.05. F, female; GM, grand mal; M, male; NA, not applicable.